The molecular basis of the failed immune response in chronic HBV: Therapeutic implications

Papatheodoridis, 2008, Therapeutic strategies in the management of patients with chronic hepatitis B virus infection, Lancet Infect Dis, 8, 167, 10.1016/S1473-3099(07)70264-5 Ilan, 1993, Ablation of persistent hepatitis B by bone marrow transplantation from a hepatitis B-immune donor, Gastroenterology, 104, 1818, 10.1016/0016-5085(93)90664-X Thimme, 2003, CD8(+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection, J Virol, 77, 68, 10.1128/JVI.77.1.68-76.2003 Maini, 2000, The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection, J Exp Med, 191, 1269, 10.1084/jem.191.8.1269 Wieland, 2004, Genomic analysis of the host response to hepatitis B virus infection, Proc Natl Acad Sci USA, 101, 6669, 10.1073/pnas.0401771101 Dunn, 2009, Temporal analysis of early immune responses in patients with acute hepatitis B virus infection, Gastroenterology, 137, 1289, 10.1053/j.gastro.2009.06.054 Dunn, 2007, Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage, J Exp Med, 204, 667, 10.1084/jem.20061287 Bertoletti, 2009, Therapeutic vaccination and novel strategies to treat chronic HBV infection, Expert Rev Gastroenterol Hepatol, 3, 561, 10.1586/egh.09.48 Boni, 2007, Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection, J Virol, 81, 4215, 10.1128/JVI.02844-06 Webster, 2004, Longitudinal analysis of CD8+ T cells specific for structural and nonstructural hepatitis B virus proteins in patients with chronic hepatitis B: implications for immunotherapy, J Virol, 78, 5707, 10.1128/JVI.78.11.5707-5719.2004 Boni, 1998, Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B, J Clin Invest, 102, 968, 10.1172/JCI3731 Boni, 2001, Lamivudine treatment can overcome cytotoxic T-cell hyporesponsiveness in chronic hepatitis B: new perspectives for immune therapy, Hepatology, 33, 963, 10.1053/jhep.2001.23045 Boni, 2003, Transient restoration of anti-viral T cell responses induced by lamivudine therapy in chronic hepatitis B, J Hepatol, 39, 595, 10.1016/S0168-8278(03)00292-7 Mueller, 2009, High antigen levels are the cause of T cell exhaustion during chronic viral infection, Proc Natl Acad Sci USA, 106, 8623, 10.1073/pnas.0809818106 Wherry, 2005, Low CD8 T-cell proliferative potential and high viral load limit the effectiveness of therapeutic vaccination, J Virol, 79, 8960, 10.1128/JVI.79.14.8960-8968.2005 Wherry, 2003, Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment, J Virol, 77, 4911, 10.1128/JVI.77.8.4911-4927.2003 Crispe, 2009, The liver as a lymphoid organ, Annu Rev Immunol, 27, 147, 10.1146/annurev.immunol.021908.132629 Lopes, 2008, Bim-mediated deletion of antigen-specific CD8 T cells in patients unable to control HBV infection, J Clin Invest, 118, 1835, 10.1172/JCI33402 Radziewicz, 2008, Impaired hepatitis C virus (HCV)-specific effector CD8+ T cells undergo massive apoptosis in the peripheral blood during acute HCV infection and in the liver during the chronic phase of infection, J Virol, 82, 9808, 10.1128/JVI.01075-08 Limmer, 2000, Efficient presentation of exogenous antigen by liver endothelial cells to CD8+ T cells results in antigen-specific T-cell tolerance, Nat Med, 6, 1348, 10.1038/82161 Bowen, 2004, The site of primary T cell activation is a determinant of the balance between intrahepatic tolerance and immunity, J Clin Invest, 114, 701, 10.1172/JCI200421593 Holz, 2008, Intrahepatic murine CD8 T-cell activation associates with a distinct phenotype leading to Bim-dependent death, Gastroenterology, 135, 989, 10.1053/j.gastro.2008.05.078 Dong, 2004, B7–H1 determines accumulation and deletion of intrahepatic CD8(+) T lymphocytes, Immunity, 20, 327, 10.1016/S1074-7613(04)00050-0 Isogawa, 2005, Oscillating CD8(+) T cell effector functions after antigen recognition in the liver, Immunity, 23, 53, 10.1016/j.immuni.2005.05.005 Diehl, 2008, Tolerogenic maturation of liver sinusoidal endothelial cells promotes B7-homolog 1-dependent CD8+ T cell tolerance, Hepatology, 47, 296, 10.1002/hep.21965 Fisicaro P, Valdatta C, Massari M, Loggi E, Biasini E, Sacchelli L, et al. Anti-viral intrahepatic T-cell responses can be restored by blocking programmed death-1 pathway in chronic hepatitis B. Gastroenterology 2009 [Epub ahead of print]. Penna, 2007, Dysfunction and functional restoration of HCV-specific CD8 responses in chronic hepatitis C virus infection, Hepatology, 45, 588, 10.1002/hep.21541 Radziewicz, 2007, Liver-infiltrating lymphocytes in chronic human hepatitis C virus infection display an exhausted phenotype with high levels of PD-1 and low levels of CD127 expression, J Virol, 81, 2545, 10.1128/JVI.02021-06 Kassel, 2009, Chronically inflamed livers up-regulate expression of inhibitory B7 family members, Hepatology, 50, 1625, 10.1002/hep.23173 Probst, 2005, Resting dendritic cells induce peripheral CD8+ T cell tolerance through PD-1 and CTLA-4, Nat Immunol, 6, 280, 10.1038/ni1165 Nakamoto N, Cho H, Shaked A, Olthoff K, Valiga ME, Kaminski M, et al. Synergistic reversal of intrahepatic HCV-specific CD8 T cell exhaustion by combined PD-1/CTLA-4 blockade. PLoS Pathog 2009;5:e1000313. Velu, 2009, Enhancing SIV-specific immunity in vivo by PD-1 blockade, Nature, 458, 206, 10.1038/nature07662 Blackburn, 2009, Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection, Nat Immunol, 10, 29, 10.1038/ni.1679 Jones, 2008, Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection, J Exp Med, 205, 2763, 10.1084/jem.20081398 Bukczynski, 2004, Costimulatory ligand 4–1BBL (CD137L) as an efficient adjuvant for human antiviral cytotoxic T cell responses, Proc Natl Acad Sci USA, 101, 1291, 10.1073/pnas.0306567101 Sabbagh L, Srokowski CC, Pulle G, Snell LM, Sedgmen BJ, Liu Y, et al. A critical role for TNF receptor-associated factor 1 and Bim down-regulation in CD8 memory T cell survival. Proc Natl Acad Sci USA 2006;103:18703–08. Wang, 2007, 4–1BBL induces TNF receptor-associated factor 1-dependent Bim modulation in human T cells and is a critical component in the costimulation-dependent rescue of functionally impaired HIV-specific CD8 T cells, J Immunol, 179, 8252, 10.4049/jimmunol.179.12.8252 Das, 2008, Functional skewing of the global CD8 T cell population in chronic hepatitis B virus infection, J Exp Med, 205, 2111, 10.1084/jem.20072076 Frumento, 2002, Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase, J Exp Med, 196, 459, 10.1084/jem.20020121 Blattman, 2003, Therapeutic use of IL-2 to enhance antiviral T-cell responses in vivo, Nat Med, 9, 540, 10.1038/nm866 Manigold, 2007, T-cell regulation by CD4 regulatory T cells during hepatitis B and C virus infections: facts and controversies, Lancet Infect Dis, 7, 804, 10.1016/S1473-3099(07)70289-X Alatrakchi N, Graham CS, van der Vliet HJ, Sherman KE, Exley MA, Koziel MJ. Hepatitis C virus (HCV)-specific CD8+ cells produce transforming growth factor beta that can suppress HCV-specific T-cell responses. J Virol 2007;81:5882–92. Tinoco, 2009, Cell-intrinsic transforming growth factor-beta signaling mediates virus-specific CD8+ T cell deletion and viral persistence in vivo, Immunity, 31, 145, 10.1016/j.immuni.2009.06.015 Weng, 2009, The etiology of liver damage imparts cytokines transforming growth factor beta1 or interleukin-13 as driving forces in fibrogenesis, Hepatology, 50, 230, 10.1002/hep.22934 Kido, 2008, Fatal autoimmune hepatitis induced by concurrent loss of naturally arising regulatory T cells and PD-1-mediated signaling, Gastroenterology, 135, 1333, 10.1053/j.gastro.2008.06.042 Ha, 2008, Enhancing therapeutic vaccination by blocking PD-1-mediated inhibitory signals during chronic infection, J Exp Med, 205, 543, 10.1084/jem.20071949 Ha, 2008, Manipulating both the inhibitory and stimulatory immune system towards the success of therapeutic vaccination against chronic viral infections, Immunol Rev, 223, 317, 10.1111/j.1600-065X.2008.00638.x Bohne F, Chmielewski M, Ebert G, Wiegmann K, Kurschner T, Schulze A, et al. T cells redirected against hepatitis B virus surface proteins eliminate infected hepatocytes. Gastroenterology 2008;134:239–47. Morgan RA, Dudley ME, Wunderlich JR, Hughes MS, Yang JC, Sherry RM, et al. Cancer regression in patients after transfer of genetically engineered lymphocytes. Science 2006;314:126–29. Guidotti, 1996, Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes, Immunity, 4, 25, 10.1016/S1074-7613(00)80295-2 Ando, 1993, Mechanisms of class I restricted immunopathology. A transgenic mouse model of fulminant hepatitis, J Exp Med, 178, 1541, 10.1084/jem.178.5.1541 Kakimi, 2001, Blocking chemokine responsive to gamma-2/interferon (IFN)-gamma inducible protein and monokine induced by IFN-gamma activity in vivo reduces the pathogenetic but not the antiviral potential of hepatitis B virus-specific cytotoxic T lymphocytes, J Exp Med, 194, 1755, 10.1084/jem.194.12.1755